Remicade News and Research

RSS
Study: Biologic therapy did not reduce IBD-related hospitalizations and surgeries

Study: Biologic therapy did not reduce IBD-related hospitalizations and surgeries

New computational framework reveals impact of arthritis drugs on gene expression

New computational framework reveals impact of arthritis drugs on gene expression

Top policy expert’s ties to giant drugmaker often go unstated

Top policy expert’s ties to giant drugmaker often go unstated

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

Biosimilars, biologics and new legal challenges for RA treatments

Biosimilars, biologics and new legal challenges for RA treatments

Without price breaks, rural hospitals struggle to stock costly, lifesaving drugs

Without price breaks, rural hospitals struggle to stock costly, lifesaving drugs

Scientists rewire mouse stem cells to fight inflammation caused by arthritis

Scientists rewire mouse stem cells to fight inflammation caused by arthritis

Generic biologic drugs appear to be as effective as brand-name versions

Generic biologic drugs appear to be as effective as brand-name versions

Celltrion Healthcare commits to develop lab tests for evidence-based decision-making in anti-TNF treatment

Celltrion Healthcare commits to develop lab tests for evidence-based decision-making in anti-TNF treatment

Antibody-positive patients treated with infliximab less likely to benefit from infliximab biosimilar

Antibody-positive patients treated with infliximab less likely to benefit from infliximab biosimilar

New study explores factors that affect Medicare patient’s adherence to psoriasis biologic therapies

New study explores factors that affect Medicare patient’s adherence to psoriasis biologic therapies

Inflectra (infliximab-dyyb) approved for multiple indications

Inflectra (infliximab-dyyb) approved for multiple indications

Remicade co-developer funds new microscopy facility on Scripps Florida campus

Remicade co-developer funds new microscopy facility on Scripps Florida campus

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

Switching from Remicade to Inflectra benefits patients with rheumatic diseases

Time for a switch for patients with rheumatoid arthritis and ankylosing spondylitis

Time for a switch for patients with rheumatoid arthritis and ankylosing spondylitis

Global RA treatment market expected to increase just over $19 billion by 2020

Global RA treatment market expected to increase just over $19 billion by 2020

Celltrion receives approval for infliximab biosimilar antibody from Brazil's ANVISA

Celltrion receives approval for infliximab biosimilar antibody from Brazil's ANVISA

Researchers explore benefits and risks of biosimilar antibodies

Researchers explore benefits and risks of biosimilar antibodies

Hospira announces availability of INFLECTRA (infliximab) in Canada

Hospira announces availability of INFLECTRA (infliximab) in Canada